Clinical trial
Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell…
NCT00004159 · University of Alabama at Birmingham, Other · Terminated
Key facts
| NCT number | NCT00004159 |
|---|---|
| Title | Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor |
| Official title | Biweekly Gemcitabine and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer and Solid Tumors: A Phase I/IIa Study |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, paclitaxel |
| Enrollment | 54 |
| Start date | Feb 1, 2000 |
| Primary completion | Feb 1, 2000 |
| Completion | Feb 1, 2000 |
| First posted | Jul 26, 2004 |
| Last update posted | Nov 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: